MedTrace Logo

The Prevalence and Risk Factors for Thyroid Dysfunction in Pregnant Women in Taiwan

NCT04936698 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-08-16

No results posted yet for this study

Summary

The investigators' aim is to enroll around 2000 patients from Taipei, Keelung, Linkou, Chiayi and Kaohsiung CGMH. All participants will receive universal thyroid function screening at 1st trimester, and those who was found to have hyperthyroidism or hypothyroidism will be referred to Endocrine department for further treatment. All participants will be followed at outpatient clinic, and their obstetric visit finding will be recorded. The maternal and neonatal outcomes will be analyzed.

Conditions

  • Thyroid Disease Pregnancy

Interventions

DRUG

PTU 50 MG Oral Tablet

to treat if the patient has hyperthyroidism

DRUG

Levothyroxin

to treat if the patient has hypothyroidism

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-16
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04936698 on ClinicalTrials.gov